Texas Instruments
TXN Nasdaq Semiconductors Financials FY2016–FY2025
Texas Instruments' revenue rose 13.1% to $17.7 billion in fiscal 2025. Its operating margin was 34.1%, down from 34.9% a year earlier. Free cash flow was $2.6 billion, up 73.8%. It paid out $6.5 billion in dividends and buybacks, 249% of free cash flow. The diluted share count fell 0.7%.
What Texas Instruments does
Texas Instruments (TI) designs and makes semiconductors, the chips inside electronic equipment, and sells them to companies that design and build electronics around the world. It offers more than 80,000 products, used in factory equipment, cars, data centers, phones and other personal electronics, and communications gear. Based in Dallas, it sells to over 100,000 customers.
TI had $17.68 billion of revenue in 2025. Its Analog segment, chips that handle real-world signals such as sound or temperature, often turning them into data, and that manage power in devices, brought in $14.01 billion, about 79% of revenue. Embedded Processing, processors built to handle specific tasks in equipment, used particularly in industrial and automotive markets, brought in $2.70 billion, about 15%. The rest, $979 million, came from projector chips, calculators and some custom chips. TI sells mostly directly, including through its website: more than 80% of 2025 revenue. It says it competes with dozens of large and small companies, including newer ones, particularly in Asia.
TI makes most of its chips in its own factories in North America, Asia, Japan and Europe, and in 2025 was ramping up production at new plants in Richardson and Sherman, Texas, and Lehi, Utah. At the end of 2025 it had about 33,000 employees.
- Legal name
- TEXAS INSTRUMENTS INCORPORATED
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 6, 2026
- Accession · CIK
- 0000097476-26-000059
0000097476
Revenue and margins
Texas Instruments had $17.7B of revenue in fiscal 2025, up 13.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 5.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.6B in fiscal 2025, 14.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Texas Instruments returned $6.5B to shareholders in fiscal 2025, 249% of free cash flow. The diluted share count fell 0.7%.
Value Texas Instruments yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$9.2B and divides by 913.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 36.9x · peers 46.4x · sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Texas Instruments can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.7B | $9.1B | $8.6B | $7.6B | $4.9B |
| Debt incl. finance leases | $7.7B | $8.7B | $11.2B | $13.6B | $14.0B |
| Net debt / EBITDA | −0.2x | −0.0x | 0.3x | 0.9x | 1.2x |
| Debt / equity | 0.6x | 0.6x | 0.7x | 0.8x | 0.9x |
| Interest coverage | 48.7x | 47.4x | 20.8x | 10.8x | 11.1x |
| Current ratio | 5.3x | 4.7x | 4.6x | 4.1x | 4.4x |
| Quick ratio | 4.6x | 3.8x | 3.4x | 2.9x | 2.8x |
| Total assets | $24.7B | $27.2B | $32.3B | $35.5B | $34.6B |
| Total liabilities | $11.3B | $12.6B | $15.5B | $18.6B | $18.3B |
| Shareholders' equity | $13.3B | $14.6B | $16.9B | $16.9B | $16.3B |
| Net debt (− = net cash) | −$2.0B | −$332M | $2.6B | $6.0B | $9.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$61.0M
12 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Tsedeniya AbrahamSr. Vice President | Sold | 7,000 | $264.63 | $1.9M | Form 4 |
| May 28, 2026 | Martin S CraigheadDirector | Sold | 10,000 | $320.43 | $3.2M | Form 4 |
| May 14, 2026 | Ahmad BahaiSr. Vice President | Sold | 5,000 | $309.13 | $1.5M | Form 4 |
| May 14, 2026 | Rafael R LizardiSr. Vice President & CFO | Sold | 47,734 | $308.10 | $14.7M | Form 4 |
| May 13, 2026 | Carrie Smith CoxDirector | Sold | 8,838 | $306.40 | $2.7M | Form 4 |
| May 11, 2026 | Shanon J LeonardSr. Vice President | Sold | 4,963 | $295.22 | $1.5M | Form 4 |
| May 4, 2026 | Haviv IlanChairman, President & CEO, Director | Sold | 20,000 | $280.32 | $5.6M | Form 4 |
| May 1, 2026 | Julie C. KnechtVP & Chief Accounting Officer | Sold | 9,956 | $278.70 | $2.8M | Form 4 |
| Apr 30, 2026 | Mark GarySr. Vice President | Sold | 13,689 | $279.25 | $3.8M | Form 4 |
| Apr 30, 2026 | Mark T. RobertsSr. Vice President | Sold | 28,080 | $280.34 | $7.9M | Form 4 |
| Apr 29, 2026 | Mohammad YunusSr. Vice President | Sold | 51,098 | $270.44 | $13.8M | Form 4 |
| Apr 27, 2026 | Katharine KaneSVP and General Counsel | Sold | 6,125 | $270.41 | $1.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✕ | ✕ |
| Current ratio rose | ✕ | ✕ | ✓ |
| Share count didn't rise | ✓ | ✕ | ✓ |
| Gross margin rose | ✕ | ✕ | ✕ |
| Revenue rose relative to assets | ✕ | ✕ | ✓ |
| F-score | 3 / 9 | 3 / 9 | 6 / 9 |
| Accruals ratio | 0.3% | −4.5% | −6.1% |
| Altman Z'' | 10.33 | 8.89 | 9.04 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Texas Instruments TXN | $262.2B | 13.1% | 34.1% | 14.7% | 21.8% | 36.9x | 6 | |
| NXP Semiconductors NXPI | $59.6B | −2.7% | 24.8% | 19.8% | 12.6% | 22.5x | 4 | Compare → |
| STMicroelectronics STM | $40.6B | −11.1% | 1.5% | — | 0.5% | — | 6 | Compare → |
| Analog Devices ADI | $191.2B | 16.9% | 26.6% | 38.8% | 6.2% | 46.5x | 8 | Compare → |
| AMD AMD | $857.4B | 34.3% | 10.7% | 19.4% | 6.7% | 132.9x | 8 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.4B | $15.0B | $15.8B | $14.4B | $14.5B | $18.3B | $20.0B | $17.5B | $15.6B | $17.7B |
| Gross profit | $8.3B | $9.6B | $10.3B | $9.2B | $9.3B | $12.4B | $13.8B | $11.0B | $9.1B | $10.1B |
| Research and development | $1.4B | $1.5B | $1.6B | $1.5B | $1.5B | $1.6B | $1.7B | $1.9B | $2.0B | $2.1B |
| Operating income | $4.9B | $6.1B | $6.7B | $5.7B | $5.9B | $9.0B | $10.1B | $7.3B | $5.5B | $6.0B |
| Interest expense | $80.0M | $78.0M | $125M | $170M | $190M | $184M | $214M | $353M | $508M | $543M |
| Pretax income | $4.9B | $6.1B | $6.7B | $5.7B | $6.0B | $8.9B | $10.0B | $7.4B | $5.5B | $5.7B |
| Income tax | $1.3B | $2.4B | $1.1B | $711M | $422M | $1.2B | $1.3B | $908M | $654M | $709M |
| Net income | $3.6B | $3.7B | $5.6B | $5.0B | $5.6B | $7.8B | $8.7B | $6.5B | $4.8B | $5.0B |
| Diluted EPS | $3.48 | $3.61 | $5.59 | $5.24 | $5.97 | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 |
| Diluted shares | 1.02B | 1.01B | 0.99B | 0.95B | 0.93B | 0.94B | 0.93B | 0.92B | 0.92B | 0.91B |
| Cash flow | ||||||||||
| Cash from operations | $4.6B | $5.4B | $7.2B | $6.6B | $6.1B | $8.8B | $8.7B | $6.4B | $6.3B | $7.2B |
| Capital expenditure | $531M | $695M | $1.1B | $847M | $649M | $2.5B | $2.8B | $5.1B | $4.8B | $4.6B |
| Free cash flow | $4.1B | $4.7B | $6.1B | $5.8B | $5.5B | $6.3B | $5.9B | $1.3B | $1.5B | $2.6B |
| Depreciation and amortization | $924M | $857M | $908M | $996M | $931M | $897M | $925M | $1.2B | $1.5B | $1.9B |
| Stock-based compensation | $252M | $242M | $232M | $217M | $224M | $230M | $289M | $362M | $387M | $419M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $2.1B | $2.6B | $5.1B | $3.0B | $2.6B | $527M | $3.6B | $293M | $929M | $1.5B |
| Dividends paid | $1.6B | $2.1B | $2.6B | $3.0B | $3.4B | $3.9B | $4.3B | $4.6B | $4.8B | $5.0B |
| Dividends and buybacks | $3.8B | $4.7B | $7.7B | $6.0B | $6.0B | $4.4B | $7.9B | $4.9B | $5.7B | $6.5B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.5B | $4.5B | $4.2B | $5.4B | $6.6B | $9.7B | $9.1B | $8.6B | $7.6B | $4.9B |
| Total debt | $3.6B | $4.1B | $5.1B | $5.8B | $6.8B | $7.7B | $8.7B | $11.2B | $13.6B | $14.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $7.5B | $8.7B | $8.1B | $8.8B | $10.2B | $13.7B | $14.0B | $15.1B | $15.0B | $13.8B |
| Current liabilities | $2.3B | $2.3B | $2.5B | $2.1B | $2.4B | $2.6B | $3.0B | $3.3B | $3.6B | $3.2B |
| Inventory | $1.8B | $2.0B | $2.2B | $2.0B | $2.0B | $1.9B | $2.8B | $4.0B | $4.5B | $4.8B |
| Property and equipment, net | $2.5B | $2.7B | $3.2B | $3.3B | $3.3B | $5.1B | $6.9B | $10.0B | $11.3B | $12.3B |
| Total assets | $16.4B | $17.6B | $17.1B | $18.0B | $19.4B | $24.7B | $27.2B | $32.3B | $35.5B | $34.6B |
| Total liabilities | $6.0B | $7.3B | $8.1B | $9.1B | $10.2B | $11.3B | $12.6B | $15.5B | $18.6B | $18.3B |
| Shareholders' equity | $10.5B | $10.3B | $9.0B | $8.9B | $9.2B | $13.3B | $14.6B | $16.9B | $16.9B | $16.3B |
| Margins | ||||||||||
| Gross margin | 61.8% | 64.3% | 65.1% | 63.7% | 64.1% | 67.5% | 68.8% | 62.9% | 58.1% | 57.0% |
| Operating margin | 36.3% | 40.7% | 42.5% | 39.8% | 40.8% | 48.8% | 50.6% | 41.9% | 34.9% | 34.1% |
| EBITDA margin | 43.2% | 46.4% | 48.3% | 46.7% | 47.2% | 53.7% | 55.3% | 48.6% | 44.6% | 44.9% |
| Net margin | 26.9% | 24.6% | 35.4% | 34.9% | 38.7% | 42.4% | 43.7% | 37.2% | 30.7% | 28.3% |
| FCF margin | 30.5% | 31.2% | 38.4% | 40.3% | 38.0% | 34.3% | 29.6% | 7.7% | 9.6% | 14.7% |
| Returns | ||||||||||
| Return on capital | 33.0% | 35.9% | 56.7% | 52.4% | 58.5% | 75.2% | 69.1% | 38.1% | 22.7% | 21.8% |
| Return on capital employed | 34.9% | 41.2% | 44.7% | 37.5% | 35.9% | 45.9% | 43.8% | 27.5% | 18.0% | 19.0% |
| Return on equity | 35.2% | 35.4% | 57.7% | 56.1% | 61.8% | 69.0% | 62.7% | 41.4% | 28.4% | 30.2% |
| Return on assets | 22.0% | 21.6% | 32.1% | 28.5% | 29.9% | 35.3% | 33.7% | 21.9% | 14.1% | 14.3% |
| Growth | ||||||||||
| Revenue growth | 2.9% | 11.9% | 5.5% | −8.9% | 0.5% | 26.9% | 9.2% | −12.5% | −10.7% | 13.1% |
| Net income growth | 20.4% | 2.4% | 51.6% | −10.1% | 11.5% | 38.9% | 12.6% | −25.6% | −26.3% | 4.2% |
| EPS growth | 23.4% | 3.7% | 54.9% | −6.3% | 13.9% | 38.4% | 13.9% | −24.9% | −26.5% | 4.8% |
| FCF growth | 6.2% | 14.3% | 29.8% | −4.2% | −5.4% | 14.6% | −5.9% | −77.2% | 11.1% | 73.8% |
| Share count change | −2.1% | −0.9% | −2.2% | −3.8% | −2.0% | 0.3% | −1.1% | −1.1% | 0.3% | −0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.0x | −0.1x | 0.1x | 0.1x | 0.0x | −0.2x | −0.0x | 0.3x | 0.9x | 1.2x |
| Debt / equity | 0.3x | 0.4x | 0.6x | 0.7x | 0.7x | 0.6x | 0.6x | 0.7x | 0.8x | 0.9x |
| Interest coverage | 60.7x | 78.0x | 53.7x | 33.7x | 31.0x | 48.7x | 47.4x | 20.8x | 10.8x | 11.1x |
| Current ratio | 3.3x | 3.9x | 3.3x | 4.1x | 4.3x | 5.3x | 4.7x | 4.6x | 4.1x | 4.4x |
| Quick ratio | 2.5x | 3.0x | 2.4x | 3.2x | 3.5x | 4.6x | 3.8x | 3.4x | 2.9x | 2.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.0% | 4.7% | 7.2% | 5.9% | 4.5% | 13.4% | 14.0% | 29.0% | 30.8% | 25.7% |
| Stock comp / revenue | 1.9% | 1.6% | 1.5% | 1.5% | 1.6% | 1.3% | 1.4% | 2.1% | 2.5% | 2.4% |
| Payouts / FCF | 92.5% | 99.8% | 126.4% | 102.9% | 108.9% | 70.1% | 133.6% | 359.5% | 382.1% | 248.8% |
| Quality scores | ||||||||||
| Piotroski F-score | 9.0 | 8.0 | 6.0 | 5.0 | 7.0 | 8.0 | 5.0 | 3.0 | 3.0 | 6.0 |
| Altman Z'' | 12.5 | 12.6 | 13.2 | 12.8 | 12.7 | 12.7 | 12.4 | 10.3 | 8.9 | 9.0 |
| Accruals ratio | −6.2% | −9.9% | −9.3% | −9.3% | −2.9% | −4.5% | 0.1% | 0.3% | −4.5% | −6.1% |
Source: SEC EDGAR XBRL filings (CIK 0000097476). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.